Gelonghui November 26th | Guizhou Sanli Pharmaceuticals (603439.SH) stated on the interactive platform that currently Guizhou Sanli Pharmaceuticals does not have any products related to snakes among its production and sales. Subsidiaries Guizhou Hanfang Pharmaceutical, Guizhou Dechangxiang, and Yunnan Wudizhi Pharmaceuticals have products with snake-related raw materials in their formulations.
贵州三力(603439.SH)：贵州三力制药在产在售的产品中没有蛇类相关的产品
guizhou sanli pharmaceutical co.,ltd. (603439.SH): There are no products related to snakes among the products currently in production and for sale at guizhou sanli pharmaceutical co.,ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha